Legal status in Latvia

Per-substance legal status for Latvia, from sourced statutes where available. Legal information, not legal advice; drug laws change, so confirm with the destination’s embassy or drug authority before you travel.

88 confirmed substances0 not individually verifiedLast updated September 20, 2026

Confirmed legal status

1P-LSD

Legal status: 1P-LSD is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name 1P-LSD separately. It is reached through the group entry «lizergamīdi (jeb lizergīnskābes amīdi)», which is lysergamides (lysergic-acid amides), and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(21) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for 1P-LSD. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,001 g, and the amount from which a quantity is recognised as large is 0,002 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places 1P-LSD in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover 1P-LSD was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for 1P-LSD, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for 1P-LSD appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, 1P-LSD, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(21), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,001 g, large from 0,002 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

1P-LSD in Latvia, full detail →

2-FDCK

Legal status: 2-FDCK is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name 2-FDCK separately. It is reached through the group entry «1-arilcikloheksilamīni un (1-arilcikloheksil)metānamīni», which is 1-arylcyclohexylamines and (1-arylcyclohexyl)methanamines, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(9) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for 2-FDCK. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,001 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places 2-FDCK in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover 2-FDCK was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for 2-FDCK, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for 2-FDCK appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, 2-FDCK, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(9), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,001 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

2-FDCK in Latvia, full detail →

25I-NBOMe

Legal status: 25I-NBOMe is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name 25I-NBOMe separately. It is reached through the group entry «2,5-dimetoksifeniletānamīni», which is 2,5-dimethoxyphenethylamines, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(1) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for 25I-NBOMe. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 2 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places 25I-NBOMe in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover 25I-NBOMe was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for 25I-NBOMe, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for 25I-NBOMe appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, 25I-NBOMe, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(1), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,02 g, large from 2 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

25I-NBOMe in Latvia, full detail →

2C-B

Legal status: 2C-B is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names 2C-B directly. The entry reads «2,5-dimetoksifeniletānamīni», which is 2,5-dimethoxyphenethylamines. The entry sits at item 11(1) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for 2C-B. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 2 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places 2C-B in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover 2C-B was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for 2C-B, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for 2C-B appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, 2C-B, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(1), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,02 g, large from 2 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

2C-B in Latvia, full detail →

2C-E

Legal status: 2C-E is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names 2C-E directly. The entry reads «2,5-dimetoksifeniletānamīni», which is 2,5-dimethoxyphenethylamines. The entry sits at item 11(1) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for 2C-E. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 2 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places 2C-E in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover 2C-E was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for 2C-E, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for 2C-E appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, 2C-E, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(1), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,02 g, large from 2 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

2C-E in Latvia, full detail →

2C-I

Legal status: 2C-I is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names 2C-I directly. The entry reads «2,5-dimetoksifeniletānamīni», which is 2,5-dimethoxyphenethylamines. The entry sits at item 11(1) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for 2C-I. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 2 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places 2C-I in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover 2C-I was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for 2C-I, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for 2C-I appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, 2C-I, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(1), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,02 g, large from 2 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

2C-I in Latvia, full detail →

2C-T-7

Legal status: 2C-T-7 is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names 2C-T-7 directly. The entry reads «2,5-dimetoksifeniletānamīni», which is 2,5-dimethoxyphenethylamines. The entry sits at item 11(1) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for 2C-T-7. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 2 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places 2C-T-7 in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover 2C-T-7 was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for 2C-T-7, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for 2C-T-7 appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, 2C-T-7, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(1), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,02 g, large from 2 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

2C-T-7 in Latvia, full detail →

3-MMC

Legal status: 3-MMC is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name 3-MMC separately. It is reached through the group entry «2-amino-1-fenilpropan-1-ons un jebkurš savienojums, kas atvasināts no 2-amino-1-fenilpropan-1-ona», which is 2-amino-1-phenylpropan-1-one and any compound derived from it, and the result is a fit to that group rather than a printed entry of its own. The entry sits in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants of Annex 2. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for 3-MMC. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 3 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places 3-MMC in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover 3-MMC was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for 3-MMC, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for 3-MMC appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, 3-MMC, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,02 g, large from 3 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

3-MMC in Latvia, full detail →

4-AcO-DMT

Legal status: 4-AcO-DMT is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name 4-AcO-DMT separately. It is reached through the group entry «triptamīni un beta-(benzofuran-3-il)etānamīni», which is tryptamines and beta-(benzofuran-3-yl)ethanamines, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(8) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for 4-AcO-DMT. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places 4-AcO-DMT in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover 4-AcO-DMT was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for 4-AcO-DMT, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for 4-AcO-DMT appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, 4-AcO-DMT, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(8), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,02 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

4-AcO-DMT in Latvia, full detail →

4-HO-MET

Legal status: 4-HO-MET is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name 4-HO-MET separately. It is reached through the group entry «triptamīni un beta-(benzofuran-3-il)etānamīni», which is tryptamines and beta-(benzofuran-3-yl)ethanamines, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(8) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for 4-HO-MET. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places 4-HO-MET in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover 4-HO-MET was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for 4-HO-MET, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for 4-HO-MET appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, 4-HO-MET, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(8), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,02 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

4-HO-MET in Latvia, full detail →

5-MeO-DMT (Bufo / Toad)

Legal status: 5-MeO-DMT is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name 5-MeO-DMT separately. It is reached through the group entry «triptamīni un beta-(benzofuran-3-il)etānamīni», which is tryptamines and beta-(benzofuran-3-yl)ethanamines, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(8) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for 5-MeO-DMT. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places 5-MeO-DMT in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover 5-MeO-DMT was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for 5-MeO-DMT, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for 5-MeO-DMT appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, 5-MeO-DMT, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(8), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,02 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

5-MeO-DMT (Bufo / Toad) in Latvia, full detail →

6-APB

Legal status: 6-APB is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name 6-APB separately. It is reached through the group entry «triptamīni un beta-(benzofuran-3-il)etānamīni», which is tryptamines and beta-(benzofuran-3-yl)ethanamines, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(8) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for 6-APB. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places 6-APB in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover 6-APB was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for 6-APB, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for 6-APB appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, 6-APB, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(8), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,02 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

6-APB in Latvia, full detail →

7-Hydroxymitragynine (7-OH)

Legal status: 7-hydroxymitragynine is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names 7-hydroxymitragynine directly. The entry reads «7-hidroksimitraginīns», which is 7-hydroxymitragynine. The entry sits at item 9(4) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for 7-hydroxymitragynine. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,03 g, and the amount from which a quantity is recognised as large is 15 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places 7-hydroxymitragynine in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover 7-hydroxymitragynine was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for 7-hydroxymitragynine, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for 7-hydroxymitragynine appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, 7-hydroxymitragynine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 9(4), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,03 g, large from 15 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

7-Hydroxymitragynine (7-OH) in Latvia, full detail →

Adderall

Legal status: Adderall is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name Adderall as such. The text relied on reads «amfetamīni (izņemot selegilīnu)», which is amphetamines (except selegiline), so the result for Adderall follows its identified constituents rather than an entry in its own name, and laboratory composition is what decides a given sample. The entry sits at item 11(3) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for Adderall. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 2 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places Adderall in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover Adderall was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for Adderall, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for Adderall appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is identified constituents rather than an entry in the substance's own name. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Adderall, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(3), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is identified constituents rather than an entry in the substance's own name · printed quantities: small up to 0,02 g, large from 2 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Adderall in Latvia, full detail →

Alcohol

Legal status: Alcohol is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for alcohol was located in it. The Latvian language search log for this row records the terms searched: etanols; spirts; alkohols; CAS 64-17-5. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach alcohol, because they attach to Annex 2 and alcohol is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that alcohol is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for alcohol in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether alcohol is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for alcohol as unread rather than as open.
Documentation: Carry alcohol as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for alcohol and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for alcohol appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, Alcohol, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for alcohol was located · Latvian search terms recorded: etanols · spirts · alkohols · CAS 64-17-5 · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Alcohol in Latvia, full detail →

Amanita muscaria

Legal status: Amanita muscaria is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name Amanita muscaria as such. The text relied on reads «halucinogēnās sēnes:... izžāvētas... neizžāvētas», which is hallucinogenic mushrooms: dried; fresh, so the result for Amanita muscaria follows its identified constituents rather than an entry in its own name, and laboratory composition is what decides a given sample. The entry sits at item 10(7) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for Amanita muscaria. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,5 g, and the amount from which a quantity is recognised as large is 5 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places Amanita muscaria in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover Amanita muscaria was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for Amanita muscaria, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for Amanita muscaria appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is identified constituents rather than an entry in the substance's own name. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Amanita muscaria, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 10(7), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is identified constituents rather than an entry in the substance's own name · printed quantities: small up to 0,5 g, large from 5 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Amanita muscaria in Latvia, full detail →

Amphetamine

Legal status: Amphetamine is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names amphetamine directly. The entry reads «amfetamīni (izņemot selegilīnu)», which is amphetamines (except selegiline). The entry sits at item 11(3) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for amphetamine. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 2 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places amphetamine in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover amphetamine was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for amphetamine, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for amphetamine appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Amphetamine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(3), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,02 g, large from 2 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Amphetamine in Latvia, full detail →

Amyl Nitrite

Legal status: Amyl nitrite is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for amyl nitrite was located in it. The Latvian language search log for this row records the terms searched: amilnitrīts; pentilnitrīts; CAS 110-46-3. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach amyl nitrite, because they attach to Annex 2 and amyl nitrite is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that amyl nitrite is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for amyl nitrite in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether amyl nitrite is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for amyl nitrite as unread rather than as open.
Documentation: Carry amyl nitrite as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for amyl nitrite and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for amyl nitrite appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, Amyl nitrite, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for amyl nitrite was located · Latvian search terms recorded: amilnitrīts · pentilnitrīts · CAS 110-46-3 · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Amyl Nitrite in Latvia, full detail →

Ayahuasca

Legal status: Ayahuasca is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name ayahuasca as such. The text relied on reads «Uz vielu maisījumiem... attiecināmi tādi paši kontroles pasākumi kā uz vielām, kuras ir to sastāvā.», which is The same control measures apply to mixtures as to the substances they contain, so the result for ayahuasca follows its identified constituents rather than an entry in its own name, and laboratory composition is what decides a given sample. The entry sits in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants of Annex 2. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for ayahuasca. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places ayahuasca in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover ayahuasca was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for ayahuasca, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for ayahuasca appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is identified constituents rather than an entry in the substance's own name. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Ayahuasca, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is identified constituents rather than an entry in the substance's own name · printed quantities: small up to 0,02 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Ayahuasca in Latvia, full detail →

Barbiturates

Legal status: Barbiturates is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Barbiturates is a family label and Annex 2 gives it no single result. The annex controls named members and prints a different amount for each, so the answer depends on which member is identified. The related annex language reads «amobarbitāls... 0,1 g... 10 g», which is amobarbital... 0.1 g... 10 g. The source does not record a schedule number for this entry. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for barbiturates. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,1 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: The source read for barbiturates does not record a schedule number, and in Latvia the schedule is what decides whether a medical route exists: Schedule I is prohibited, Schedules II and III keep a substance available for medical and scientific purposes, and Schedule IV covers precursors. Without the schedule this row cannot state the route. That is a gap in what was read rather than a finding that no route exists. The State Agency of Medicines of Latvia is the body that settles it.
Documentation: Carry the prescription and the original dispensing packaging for barbiturates, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for barbiturates appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is named members of the family, each with its own printed amount. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Barbiturates, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, with no schedule number recorded · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is named members of the family, each with its own printed amount · printed quantities: small up to 0,1 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Barbiturates in Latvia, full detail →

Benzodiazepines

Legal status: Benzodiazepines is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Benzodiazepines is a family label and Annex 2 gives it no single result. The annex controls named members and prints a different amount for each, so the answer depends on which member is identified. The related annex language reads «alprazolāms... 0,001 g... 1 g», which is alprazolam... 0.001 g... 1 g. The entry sits in Schedule III, which covers dangerous psychotropic substances of Annex 2. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for benzodiazepines. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,001 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for benzodiazepines and it runs inside the control regime rather than around it. Annex 2 places it in Schedule III, as a dangerous psychotropic substance, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for benzodiazepines, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for benzodiazepines appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is named members of the family, each with its own printed amount. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Benzodiazepines, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, in Schedule III, which covers dangerous psychotropic substances · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is named members of the family, each with its own printed amount · printed quantities: small up to 0,001 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Benzodiazepines in Latvia, full detail →

Buprenorphine

Legal status: Buprenorphine is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names buprenorphine directly. The entry reads «buprenorfīns», which is buprenorphine. The entry sits at item 14(2) of Annex 2, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for buprenorphine. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,001 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for buprenorphine and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for buprenorphine, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for buprenorphine appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Buprenorphine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 14(2), in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,001 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Buprenorphine in Latvia, full detail →

Caffeine

Legal status: Caffeine is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for caffeine was located in it. The Latvian language search log for this row records the terms searched: kofeīns; caffeine; CAS 58-08-2. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach caffeine, because they attach to Annex 2 and caffeine is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that caffeine is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for caffeine in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether caffeine is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for caffeine as unread rather than as open.
Documentation: Carry caffeine as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for caffeine and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for caffeine appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, Caffeine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for caffeine was located · Latvian search terms recorded: kofeīns · caffeine · CAS 58-08-2 · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Caffeine in Latvia, full detail →

Cannabinol

Legal status: Cannabinol is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names cannabinol directly. The entry reads «dibenzopirāni», which is dibenzopyrans. The entry sits at item 11(10) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for cannabinol. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,003 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places cannabinol in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover cannabinol was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for cannabinol, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for cannabinol appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Cannabinol, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(10), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,003 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Cannabinol in Latvia, full detail →

Cannabis / THC

Legal status: Cannabis is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names cannabis directly. The entry reads «kanabiss:... neizžāvēta marihuāna... izžāvēta marihuāna... hašišs... kanabisa sveķi, eļļa, ekstrakti un tinktūras», which is cannabis: fresh marijuana; dried marijuana; hashish; cannabis resin, oil, extracts and tinctures. The entry sits at item 7(4) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for cannabis. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 5 g, and the amount from which a quantity is recognised as large is 1 kg. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places cannabis in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover cannabis was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for cannabis, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for cannabis appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Cannabis, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 7(4), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 5 g, large from 1 kg · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Cannabis / THC in Latvia, full detail →

Cathinone

Legal status: Cathinone is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names cathinone directly. The entry reads «2-amino-1-fenilpropan-1-ons un jebkurš savienojums, kas atvasināts no 2-amino-1-fenilpropan-1-ona», which is 2-amino-1-phenylpropan-1-one and any compound derived from it. The entry sits in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants of Annex 2. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for cathinone. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 3 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places cathinone in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover cathinone was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for cathinone, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for cathinone appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Cathinone, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,02 g, large from 3 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Cathinone in Latvia, full detail →

CBD

Legal status: CBD is excluded by name from the entry that would otherwise control it in Latvia, so it is not itself a controlled substance under that entry, and a product containing it can still be caught through another listed constituent. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 addresses CBD by expressly excluding it. The entry reads «Kanabinols un no kanabinola un kanabidiola atvasināti savienojumi (izņemot kanabidiolu)», which is Cannabinol and compounds derived from cannabinol and cannabidiol (excluding cannabidiol), so the exclusion is written into the controlling entry itself rather than inferred from an absence. The entry sits at item 11(10) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available here. The 15 year ceiling under subsection (3) of Criminal Law section 253 with a superscript one is not assigned to CBD itself, because the controlling entry excludes it by name, and Annex 2 prints no small ceiling and no large floor for it. That ceiling becomes live only if the product in question contains another listed constituent, and then it attaches to that constituent rather than to CBD. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is no controlled drug prescription question for CBD itself, because the entry that would control it excludes it by name. That is a stronger statement than an absence: the instrument considered CBD and carved it out rather than passing over it. Whether a product containing CBD is available on prescription, over the counter or on general sale depends on what else that product contains and on the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it.
Documentation: Carry the prescription and the original dispensing packaging for CBD, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for CBD appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is an express exclusion written into the controlling entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, CBD, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(10), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is an express exclusion written into the controlling entry · Annex 2 prints no single quantity pair for this row · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

CBD in Latvia, full detail →

Clonazepam

Legal status: Clonazepam is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names clonazepam directly. The entry reads «klonazepāms», which is clonazepam. The entry sits at item 16(35) of Annex 2, in Schedule III, which covers dangerous psychotropic substances. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for clonazepam. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,06 g, and the amount from which a quantity is recognised as large is 5 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for clonazepam and it runs inside the control regime rather than around it. Annex 2 places it in Schedule III, as a dangerous psychotropic substance, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for clonazepam, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for clonazepam appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Clonazepam, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 16(35), in Schedule III, which covers dangerous psychotropic substances · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,06 g, large from 5 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Clonazepam in Latvia, full detail →

Cocaine

Legal status: Cocaine is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names cocaine directly. The entry reads «kokaīns», which is cocaine. The entry sits at item 13(55) of Annex 2, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for cocaine. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,01 g, and the amount from which a quantity is recognised as large is 5 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for cocaine and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for cocaine, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for cocaine appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Cocaine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 13(55), in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,01 g, large from 5 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Cocaine in Latvia, full detail →

Codeine

Legal status: Codeine is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names codeine directly. The entry reads «kodeīns», which is codeine. The entry sits at item 13(53) of Annex 2, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for codeine. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,2 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for codeine and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for codeine, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for codeine appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Codeine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 13(53), in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,2 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Codeine in Latvia, full detail →

Crack Cocaine

Legal status: Crack cocaine is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names crack cocaine directly. The entry reads «kokaīns», which is cocaine. The entry sits at item 13(55) of Annex 2, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for crack cocaine. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,01 g, and the amount from which a quantity is recognised as large is 5 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for crack cocaine and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for crack cocaine, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for crack cocaine appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Crack cocaine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 13(55), in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,01 g, large from 5 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Crack Cocaine in Latvia, full detail →

Delta-8-THC

Legal status: Delta-8-THC is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name delta-8-THC separately. It is reached through the group entry «dibenzopirāni», which is dibenzopyrans, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(10) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for delta-8-THC. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,003 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places delta-8-THC in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover delta-8-THC was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for delta-8-THC, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for delta-8-THC appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Delta-8-THC, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(10), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,003 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Delta-8-THC in Latvia, full detail →

Diazepam

Legal status: Diazepam is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names diazepam directly. The entry reads «diazepāms», which is diazepam. The entry sits at item 16(14) of Annex 2, in Schedule III, which covers dangerous psychotropic substances. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for diazepam. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,1 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for diazepam and it runs inside the control regime rather than around it. Annex 2 places it in Schedule III, as a dangerous psychotropic substance, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for diazepam, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for diazepam appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Diazepam, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 16(14), in Schedule III, which covers dangerous psychotropic substances · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,1 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Diazepam in Latvia, full detail →

DMT

Legal status: DMT is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names DMT directly. The entry reads «triptamīni un beta-(benzofuran-3-il)etānamīni», which is tryptamines and beta-(benzofuran-3-yl)ethanamines. The entry sits at item 11(8) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for DMT. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places DMT in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover DMT was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for DMT, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for DMT appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, DMT, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(8), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,02 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

DMT in Latvia, full detail →

DOM

Legal status: DOM is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name DOM separately. It is reached through the group entry «2,5-dimetoksifeniletānamīni», which is 2,5-dimethoxyphenethylamines, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(1) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for DOM. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 2 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places DOM in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover DOM was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for DOM, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for DOM appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, DOM, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(1), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,02 g, large from 2 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

DOM in Latvia, full detail →

DXM

Legal status: DXM is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for DXM was located in it. The Latvian language search log for this row records the terms searched: dekstrometorfāns; dextromethorphan; CAS 125-71-3. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach DXM, because they attach to Annex 2 and DXM is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that DXM is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for DXM in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether DXM is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for DXM as unread rather than as open.
Documentation: Carry DXM as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for DXM and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for DXM appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, DXM, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for DXM was located · Latvian search terms recorded: dekstrometorfāns · dextromethorphan · CAS 125-71-3 · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

DXM in Latvia, full detail →

Ephedrine

Legal status: Ephedrine is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names ephedrine directly. The entry reads «efedrīns», which is ephedrine. The entry sits at item 16(15) of Annex 2, in Schedule III, which covers dangerous psychotropic substances. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for ephedrine. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,6 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for ephedrine and it runs inside the control regime rather than around it. Annex 2 places it in Schedule III, as a dangerous psychotropic substance, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for ephedrine, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for ephedrine appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Ephedrine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 16(15), in Schedule III, which covers dangerous psychotropic substances · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,6 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Ephedrine in Latvia, full detail →

Etizolam

Legal status: Etizolam is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names etizolam directly. The entry reads «etizolāms», which is etizolam. The entry sits at item 16(20) of Annex 2, in Schedule III, which covers dangerous psychotropic substances. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for etizolam. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,01 g, and the amount from which a quantity is recognised as large is 5 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for etizolam and it runs inside the control regime rather than around it. Annex 2 places it in Schedule III, as a dangerous psychotropic substance, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for etizolam, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for etizolam appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Etizolam, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 16(20), in Schedule III, which covers dangerous psychotropic substances · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,01 g, large from 5 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Etizolam in Latvia, full detail →

Fentanyl

Legal status: Fentanyl is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names fentanyl directly. The entry reads «fentanils», which is fentanyl. The entry sits at item 13(42) of Annex 2, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for fentanyl. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,001 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for fentanyl and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for fentanyl, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for fentanyl appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Fentanyl, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 13(42), in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,001 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Fentanyl in Latvia, full detail →

Gabapentin

Legal status: Gabapentin is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for gabapentin was located in it. The Latvian language search log for this row records the terms searched: gabapentīns; gabapentin; CAS 60142-96-3. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach gabapentin, because they attach to Annex 2 and gabapentin is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that gabapentin is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for gabapentin in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether gabapentin is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for gabapentin as unread rather than as open.
Documentation: Carry gabapentin as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for gabapentin and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for gabapentin appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, Gabapentin, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for gabapentin was located · Latvian search terms recorded: gabapentīns · gabapentin · CAS 60142-96-3 · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Gabapentin in Latvia, full detail →

GBL

Legal status: GBL is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names GBL directly. The entry reads «gamma-butirolaktons (GBL)», which is gamma-butyrolactone (GBL). The entry sits in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes of Annex 2. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for GBL. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,6 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for GBL and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for GBL, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for GBL appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, GBL, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,6 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

GBL in Latvia, full detail →

GHB

Legal status: GHB is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names GHB directly. The entry reads «hidroksibutirskābe, gamma (GHB)», which is gamma-hydroxybutyric acid (GHB). The entry sits at item 14(10) of Annex 2, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for GHB. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,6 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for GHB and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for GHB, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for GHB appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, GHB, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 14(10), in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,6 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

GHB in Latvia, full detail →

Heroin

Legal status: Heroin is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names heroin directly. The entry reads «heroīns, morfīna diacetāts», which is heroin, morphine diacetate. The entry sits at item 6(1) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for heroin. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,001 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places heroin in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover heroin was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for heroin, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for heroin appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Heroin, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 6(1), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,001 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Heroin in Latvia, full detail →

HHC

Legal status: HHC is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name HHC separately. It is reached through the group entry «dibenzopirāni», which is dibenzopyrans, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(10) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for HHC. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,003 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places HHC in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover HHC was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for HHC, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for HHC appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, HHC, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(10), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,003 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

HHC in Latvia, full detail →

Hydrocodone

Legal status: Hydrocodone is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names hydrocodone directly. The entry reads «hidrokodons», which is hydrocodone. The entry sits at item 13(46) of Annex 2, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for hydrocodone. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,2 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for hydrocodone and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for hydrocodone, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for hydrocodone appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Hydrocodone, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 13(46), in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,2 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Hydrocodone in Latvia, full detail →

Ketamine

Legal status: Ketamine is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names ketamine directly. The entry reads «ketamīns», which is ketamine. The entry sits in Schedule III, which covers dangerous psychotropic substances of Annex 2. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for ketamine. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,6 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for ketamine and it runs inside the control regime rather than around it. Annex 2 places it in Schedule III, as a dangerous psychotropic substance, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for ketamine, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for ketamine appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Ketamine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, in Schedule III, which covers dangerous psychotropic substances · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,6 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Ketamine in Latvia, full detail →

Khat

Legal status: Khat is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names khat directly. The entry reads «catha edulis... izžāvēts... neizžāvēts», which is Catha edulis, dried/fresh. The entry sits in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants of Annex 2. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for khat. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 100 g, and the amount from which a quantity is recognised as large is 10 kg. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places khat in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover khat was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for khat, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for khat appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Khat, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 100 g, large from 10 kg · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Khat in Latvia, full detail →

Kratom

Legal status: Kratom is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names kratom directly. The entry reads «mitragyna speciosa (kratom)», which is Mitragyna speciosa (kratom). The entry sits in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants of Annex 2. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for kratom. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 1 g, and the amount from which a quantity is recognised as large is 100 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places kratom in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover kratom was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for kratom, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for kratom appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Kratom, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 1 g, large from 100 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Kratom in Latvia, full detail →

Lorazepam

Legal status: Lorazepam is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names lorazepam directly. The entry reads «lorazepāms», which is lorazepam. The entry sits at item 16(40) of Annex 2, in Schedule III, which covers dangerous psychotropic substances. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for lorazepam. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 5 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for lorazepam and it runs inside the control regime rather than around it. Annex 2 places it in Schedule III, as a dangerous psychotropic substance, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for lorazepam, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for lorazepam appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Lorazepam, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 16(40), in Schedule III, which covers dangerous psychotropic substances · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,02 g, large from 5 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Lorazepam in Latvia, full detail →

LSA (Morning Glory)

Legal status: LSA is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names LSA directly. The entry reads «lizergamīdi (jeb lizergīnskābes amīdi)», which is lysergamides (lysergic-acid amides). The entry sits at item 11(21) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for LSA. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,001 g, and the amount from which a quantity is recognised as large is 0,002 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places LSA in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover LSA was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for LSA, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for LSA appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, LSA, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(21), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,001 g, large from 0,002 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

LSA (Morning Glory) in Latvia, full detail →

LSD

Legal status: LSD is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names LSD directly. The entry reads «lizergamīdi (jeb lizergīnskābes amīdi)», which is lysergamides (lysergic-acid amides). The entry sits at item 11(21) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for LSD. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,001 g, and the amount from which a quantity is recognised as large is 0,002 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places LSD in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover LSD was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for LSD, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for LSD appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, LSD, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(21), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,001 g, large from 0,002 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

LSD in Latvia, full detail →

MDA

Legal status: MDA is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name MDA separately. It is reached through the group entry «3,4-metilēndioksifeniletānamīni», which is 3,4-methylenedioxyphenethylamines, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(2) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for MDA. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places MDA in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover MDA was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for MDA, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for MDA appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, MDA, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(2), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,02 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

MDA in Latvia, full detail →

MDMA

Legal status: MDMA is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name MDMA separately. It is reached through the group entry «3,4-metilēndioksifeniletānamīni», which is 3,4-methylenedioxyphenethylamines, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(2) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for MDMA. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places MDMA in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover MDMA was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for MDMA, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for MDMA appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, MDMA, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(2), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,02 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

MDMA in Latvia, full detail →

MDPV

Legal status: MDPV is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name MDPV separately. It is reached through the group entry «2-amino-1-fenilpropan-1-ons un jebkurš savienojums, kas atvasināts no 2-amino-1-fenilpropan-1-ona», which is 2-amino-1-phenylpropan-1-one and any compound derived from it, and the result is a fit to that group rather than a printed entry of its own. The entry sits in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants of Annex 2. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for MDPV. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 3 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places MDPV in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover MDPV was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for MDPV, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for MDPV appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, MDPV, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,02 g, large from 3 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

MDPV in Latvia, full detail →

Memantine

Legal status: Memantine is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for memantine was located in it. The Latvian language search log for this row records the terms searched: memantīns; memantine; CAS 19982-08-2. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach memantine, because they attach to Annex 2 and memantine is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that memantine is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for memantine in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether memantine is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for memantine as unread rather than as open.
Documentation: Carry memantine as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for memantine and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for memantine appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, Memantine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for memantine was located · Latvian search terms recorded: memantīns · memantine · CAS 19982-08-2 · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Memantine in Latvia, full detail →

Mephedrone (4-MMC)

Legal status: Mephedrone is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name mephedrone separately. It is reached through the group entry «2-amino-1-fenilpropan-1-ons un jebkurš savienojums, kas atvasināts no 2-amino-1-fenilpropan-1-ona», which is 2-amino-1-phenylpropan-1-one and any compound derived from it, and the result is a fit to that group rather than a printed entry of its own. The entry sits in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants of Annex 2. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for mephedrone. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 3 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places mephedrone in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover mephedrone was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for mephedrone, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for mephedrone appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Mephedrone, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,02 g, large from 3 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Mephedrone (4-MMC) in Latvia, full detail →

Mescaline

Legal status: Mescaline is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names mescaline directly. The entry reads «meskalīns», which is mescaline. The entry sits at item 9(1) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for mescaline. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,03 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places mescaline in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover mescaline was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for mescaline, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for mescaline appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Mescaline, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 9(1), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,03 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Mescaline in Latvia, full detail →

Methadone

Legal status: Methadone is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names methadone directly. The entry reads «metadons», which is methadone. The entry sits at item 13(60) of Annex 2, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for methadone. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,01 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for methadone and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for methadone, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for methadone appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Methadone, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 13(60), in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,01 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Methadone in Latvia, full detail →

Methamphetamine

Legal status: Methamphetamine is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name methamphetamine separately. It is reached through the group entry «amfetamīni (izņemot selegilīnu)», which is amphetamines (except selegiline), and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(3) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for methamphetamine. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 2 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places methamphetamine in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover methamphetamine was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for methamphetamine, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for methamphetamine appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Methamphetamine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(3), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,02 g, large from 2 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Methamphetamine in Latvia, full detail →

Methaqualone (Quaaludes)

Legal status: Methaqualone is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names methaqualone directly. The entry reads «metakvalons», which is methaqualone. The entry sits at item 14(13) of Annex 2, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for methaqualone. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,05 g, and the amount from which a quantity is recognised as large is 5 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for methaqualone and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for methaqualone, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for methaqualone appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Methaqualone, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 14(13), in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,05 g, large from 5 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Methaqualone (Quaaludes) in Latvia, full detail →

Methylone

Legal status: Methylone is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name methylone separately. It is reached through the group entry «3,4-metilēndioksifeniletānamīni», which is 3,4-methylenedioxyphenethylamines, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(2) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for methylone. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places methylone in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover methylone was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for methylone, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for methylone appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Methylone, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(2), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,02 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Methylone in Latvia, full detail →

Methylphenidate

Legal status: Methylphenidate is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names methylphenidate directly. The entry reads «metilfenidāts», which is methylphenidate. The entry sits at item 14(14) of Annex 2, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for methylphenidate. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,2 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for methylphenidate and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for methylphenidate, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for methylphenidate appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Methylphenidate, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 14(14), in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,2 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Methylphenidate in Latvia, full detail →

Mitragynine

Legal status: Mitragynine is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names mitragynine directly. The entry reads «mitraginīns», which is mitragynine. The entry sits at item 9(5) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for mitragynine. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,03 g, and the amount from which a quantity is recognised as large is 3 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places mitragynine in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover mitragynine was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for mitragynine, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for mitragynine appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Mitragynine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 9(5), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,03 g, large from 3 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Mitragynine in Latvia, full detail →

Modafinil

Legal status: Modafinil is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for modafinil was located in it. The Latvian language search log for this row records the terms searched: modafinils; modafinil; CAS 68693-11-8. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach modafinil, because they attach to Annex 2 and modafinil is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that modafinil is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for modafinil in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether modafinil is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for modafinil as unread rather than as open.
Documentation: Carry modafinil as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for modafinil and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for modafinil appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, Modafinil, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for modafinil was located · Latvian search terms recorded: modafinils · modafinil · CAS 68693-11-8 · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Modafinil in Latvia, full detail →

Morphine

Legal status: Morphine is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names morphine directly. The entry reads «morfīns», which is morphine. The entry sits at item 13(68) of Annex 2, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for morphine. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,01 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for morphine and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for morphine, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for morphine appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Morphine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 13(68), in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,01 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Morphine in Latvia, full detail →

MXE

Legal status: MXE is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name MXE separately. It is reached through the group entry «1-arilcikloheksilamīni un (1-arilcikloheksil)metānamīni», which is 1-arylcyclohexylamines and (1-arylcyclohexyl)methanamines, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(9) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for MXE. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,001 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places MXE in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover MXE was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for MXE, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for MXE appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, MXE, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(9), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,001 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

MXE in Latvia, full detail →

Nicotine

Legal status: Nicotine is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for nicotine was located in it. The Latvian language search log for this row records the terms searched: nikotīns; nicotine; CAS 54-11-5. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach nicotine, because they attach to Annex 2 and nicotine is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that nicotine is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for nicotine in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether nicotine is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for nicotine as unread rather than as open.
Documentation: Carry nicotine as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for nicotine and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for nicotine appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, Nicotine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for nicotine was located · Latvian search terms recorded: nikotīns · nicotine · CAS 54-11-5 · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Nicotine in Latvia, full detail →

Nimetazepam

Legal status: Nimetazepam is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names nimetazepam directly. The entry reads «nimetazepāms», which is nimetazepam. The entry sits at item 16(50) of Annex 2, in Schedule III, which covers dangerous psychotropic substances. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for nimetazepam. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,6 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for nimetazepam and it runs inside the control regime rather than around it. Annex 2 places it in Schedule III, as a dangerous psychotropic substance, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for nimetazepam, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for nimetazepam appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Nimetazepam, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 16(50), in Schedule III, which covers dangerous psychotropic substances · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,6 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Nimetazepam in Latvia, full detail →

Nitrous Oxide

Legal status: Nitrous oxide is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for nitrous oxide was located in it. The Latvian language search log for this row records the terms searched: slāpekļa oksiduls; dislāpekļa monoksīds; CAS 10024-97-2. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach nitrous oxide, because they attach to Annex 2 and nitrous oxide is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that nitrous oxide is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for nitrous oxide in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether nitrous oxide is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for nitrous oxide as unread rather than as open.
Documentation: Carry nitrous oxide as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for nitrous oxide and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for nitrous oxide appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, Nitrous oxide, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for nitrous oxide was located · Latvian search terms recorded: slāpekļa oksiduls · dislāpekļa monoksīds · CAS 10024-97-2 · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Nitrous Oxide in Latvia, full detail →

Opium

Legal status: Opium is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names opium directly. The entry reads «opijs», which is opium. The entry sits at item 13(83) of Annex 2, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for opium. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,1 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for opium and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for opium, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for opium appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Opium, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 13(83), in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,1 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Opium in Latvia, full detail →

Oxycodone

Legal status: Oxycodone is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names oxycodone directly. The entry reads «oksikodons», which is oxycodone. The entry sits at item 13(81) of Annex 2, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for oxycodone. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,2 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for oxycodone and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for oxycodone, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for oxycodone appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Oxycodone, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 13(81), in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,2 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Oxycodone in Latvia, full detail →

PCP

Legal status: PCP is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names PCP directly. The entry reads «fenciklidīns (PCP)», which is phencyclidine (PCP). The entry sits at item 14(7) of Annex 2, in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for PCP. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,001 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for PCP and it runs inside the control regime rather than around it. Annex 2 places it in Schedule II, as a very dangerous substance that remains available for medical and scientific purposes, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for PCP, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for PCP appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, PCP, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 14(7), in Schedule II, which covers very dangerous substances that remain available for medical and scientific purposes · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,001 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

PCP in Latvia, full detail →

Peyote

Legal status: Peyote is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name peyote as such. The text relied on reads «meskalīns... 0,03 g... 1 g», which is mescaline... 0.03 g... 1 g, so the result for peyote follows its identified constituents rather than an entry in its own name, and laboratory composition is what decides a given sample. The entry sits in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants of Annex 2. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for peyote. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,03 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places peyote in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover peyote was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for peyote, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for peyote appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is identified constituents rather than an entry in the substance's own name. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Peyote, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is identified constituents rather than an entry in the substance's own name · printed quantities: small up to 0,03 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Peyote in Latvia, full detail →

Phenibut

Legal status: Phenibut is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for phenibut was located in it. The Latvian language search log for this row records the terms searched: fenibuts; phenibut; CAS 1078-21-3. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach phenibut, because they attach to Annex 2 and phenibut is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that phenibut is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for phenibut in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether phenibut is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for phenibut as unread rather than as open.
Documentation: Carry phenibut as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for phenibut and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for phenibut appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, Phenibut, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for phenibut was located · Latvian search terms recorded: fenibuts · phenibut · CAS 1078-21-3 · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Phenibut in Latvia, full detail →

Pink Cocaine / Tusi

Legal status: Pink cocaine is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name pink cocaine as such. The text relied on reads «Ja vielu maisījumā... ietilpst vairākas sarakstos iekļautās vielas, piemērojami... stingrāk kontrolējamās vielas [nosacījumi].», which is If a mixture contains several listed substances, the conditions for the most strictly controlled constituent apply, so the result for pink cocaine follows its identified constituents rather than an entry in its own name, and laboratory composition is what decides a given sample. The source does not record a schedule number for this entry. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for pink cocaine. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints no single small ceiling or large floor for this row, so the quantity bands have to be taken from the identified member or constituent. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: The source read for pink cocaine does not record a schedule number, and in Latvia the schedule is what decides whether a medical route exists: Schedule I is prohibited, Schedules II and III keep a substance available for medical and scientific purposes, and Schedule IV covers precursors. Without the schedule this row cannot state the route. That is a gap in what was read rather than a finding that no route exists. The State Agency of Medicines of Latvia is the body that settles it.
Documentation: Carry the prescription and the original dispensing packaging for pink cocaine, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for pink cocaine appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is identified constituents rather than an entry in the substance's own name. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Pink cocaine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, with no schedule number recorded · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is identified constituents rather than an entry in the substance's own name · Annex 2 prints no single quantity pair for this row · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Pink Cocaine / Tusi in Latvia, full detail →

Poppers

Legal status: Poppers is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for poppers was located in it. The Latvian language search log for this row records the terms searched: poppers; alkilnitrīti; amilnitrīts. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach poppers, because they attach to Annex 2 and poppers is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that poppers is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for poppers in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether poppers is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for poppers as unread rather than as open.
Documentation: Carry poppers as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for poppers and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for poppers appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, Poppers, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for poppers was located · Latvian search terms recorded: poppers · alkilnitrīti · amilnitrīts · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Poppers in Latvia, full detail →

Pregabalin

Legal status: Pregabalin is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names pregabalin directly. The entry reads «pregabalīns», which is pregabalin. The entry sits in Schedule III, which covers dangerous psychotropic substances of Annex 2. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for pregabalin. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,6 g, and the amount from which a quantity is recognised as large is 6 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for pregabalin and it runs inside the control regime rather than around it. Annex 2 places it in Schedule III, as a dangerous psychotropic substance, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for pregabalin, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for pregabalin appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Pregabalin, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, in Schedule III, which covers dangerous psychotropic substances · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,6 g, large from 6 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Pregabalin in Latvia, full detail →

Psilocybin

Legal status: Psilocybin is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name psilocybin separately. It is reached through the group entry «triptamīni un beta-(benzofuran-3-il)etānamīni», which is tryptamines and beta-(benzofuran-3-yl)ethanamines, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(8) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for psilocybin. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,02 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places psilocybin in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover psilocybin was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for psilocybin, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for psilocybin appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Psilocybin, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(8), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,02 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Psilocybin in Latvia, full detail →

Quetiapine

Legal status: Quetiapine is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for quetiapine was located in it. The Latvian language search log for this row records the terms searched: kvetiapīns; quetiapine; CAS 111974-69-7. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach quetiapine, because they attach to Annex 2 and quetiapine is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that quetiapine is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for quetiapine in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether quetiapine is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for quetiapine as unread rather than as open.
Documentation: Carry quetiapine as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for quetiapine and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for quetiapine appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, Quetiapine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for quetiapine was located · Latvian search terms recorded: kvetiapīns · quetiapine · CAS 111974-69-7 · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Quetiapine in Latvia, full detail →

Salvia divinorum

Legal status: Salvia divinorum is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names Salvia divinorum directly. The entry reads «salvia divinorum», which is Salvia divinorum. The entry sits in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants of Annex 2. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for Salvia divinorum. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 1 g, and the amount from which a quantity is recognised as large is 100 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places Salvia divinorum in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover Salvia divinorum was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for Salvia divinorum, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for Salvia divinorum appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Salvia divinorum, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 1 g, large from 100 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Salvia divinorum in Latvia, full detail →

Scopolamine (Devil's Breath)

Legal status: Scopolamine is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for scopolamine was located in it. The Latvian language search log for this row records the terms searched: skopolamīns; scopolamine; CAS 51-34-3. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach scopolamine, because they attach to Annex 2 and scopolamine is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that scopolamine is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for scopolamine in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether scopolamine is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for scopolamine as unread rather than as open.
Documentation: Carry scopolamine as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for scopolamine and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for scopolamine appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, Scopolamine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for scopolamine was located · Latvian search terms recorded: skopolamīns · scopolamine · CAS 51-34-3 · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Scopolamine (Devil's Breath) in Latvia, full detail →

Synthetic Cannabinoids (K2 / Spice)

Legal status: Synthetic cannabinoids is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names synthetic cannabinoids directly. The entry reads «dibenzopirāni», which is dibenzopyrans. The entry sits at item 11(10) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for synthetic cannabinoids. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,003 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places synthetic cannabinoids in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover synthetic cannabinoids was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for synthetic cannabinoids, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for synthetic cannabinoids appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Synthetic cannabinoids, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(10), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,003 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Synthetic Cannabinoids (K2 / Spice) in Latvia, full detail →

THC-P

Legal status: THC-P is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 does not name THC-P separately. It is reached through the group entry «dibenzopirāni», which is dibenzopyrans, and the result is a fit to that group rather than a printed entry of its own. The entry sits at item 11(10) of Annex 2, in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for THC-P. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,003 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: Latvia places THC-P in the prohibited schedule, so there is no ordinary prescription route. Schedule I of Annex 2 covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants, and that placement is the strongest control the annex carries. Authorised scientific or forensic handling runs through the Circulation Law licensing provisions rather than through a prescription. Whether such an authorisation could cover THC-P was not audited for this row and is a question for the State Agency of Medicines of Latvia.
Documentation: Carry the prescription and the original dispensing packaging for THC-P, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for THC-P appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a group entry rather than a named one. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, THC-P, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 11(10), in Schedule I, which covers prohibited especially dangerous narcotic and equivalent psychotropic substances and plants · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a group entry rather than a named one · printed quantities: small up to 0,003 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

THC-P in Latvia, full detail →

Tobacco

Legal status: Tobacco is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for tobacco was located in it. The Latvian language search log for this row records the terms searched: tabaka; tobacco; Nicotiana. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach tobacco, because they attach to Annex 2 and tobacco is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that tobacco is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for tobacco in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether tobacco is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for tobacco as unread rather than as open.
Documentation: Carry tobacco as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for tobacco and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for tobacco appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, Tobacco, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for tobacco was located · Latvian search terms recorded: tabaka · tobacco · Nicotiana · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Tobacco in Latvia, full detail →

Tramadol

Legal status: Tramadol is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names tramadol directly. The entry reads «tramadols», which is tramadol. The entry sits at item 16(68) of Annex 2, in Schedule III, which covers dangerous psychotropic substances. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for tramadol. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,5 g, and the amount from which a quantity is recognised as large is 6 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for tramadol and it runs inside the control regime rather than around it. Annex 2 places it in Schedule III, as a dangerous psychotropic substance, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for tramadol, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for tramadol appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Tramadol, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 16(68), in Schedule III, which covers dangerous psychotropic substances · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,5 g, large from 6 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Tramadol in Latvia, full detail →

Xanax (Alprazolam)

Legal status: Alprazolam is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names alprazolam directly. The entry reads «alprazolāms», which is alprazolam. The entry sits at item 16(2) of Annex 2, in Schedule III, which covers dangerous psychotropic substances. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for alprazolam. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,001 g, and the amount from which a quantity is recognised as large is 1 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for alprazolam and it runs inside the control regime rather than around it. Annex 2 places it in Schedule III, as a dangerous psychotropic substance, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for alprazolam, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for alprazolam appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Alprazolam, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 16(2), in Schedule III, which covers dangerous psychotropic substances · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,001 g, large from 1 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Xanax (Alprazolam) in Latvia, full detail →

Xylazine

Legal status: Xylazine is not listed in the Latvian controlled substances annex. Annex 2 to the law on the entry into force and application of the Criminal Law is the current list, because section 3(2) of the Circulation Law points to it expressly, and no entry for xylazine was located in it. The Latvian language search log for this row records the terms searched: ksilazīns; xylazine; CAS 7361-61-7. The search was run in Latvian rather than in English, which matters because the annex is printed in Latvian and an English search returns a false absence. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025. An absence is a statement about a list at a moment, and this one is stated as at that version and no later.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, and in any event none of the drug penalties reach xylazine, because they attach to Annex 2 and xylazine is not on it. The 15 year drug ceiling under subsection (3) of Criminal Law section 253 with a superscript one is therefore not assigned on this record, and Annex 2 prints no small ceiling and no large floor. That is not a statement that xylazine is unregulated in Latvia. It is a statement that the controlled drug offence scale is not the instrument that regulates it, and this row did not audit whichever regime does.
If prescribed / medical: There is no controlled drug prescription question for xylazine in Latvia, because Annex 2 does not carry it and the Circulation Law licensing and prescribing machinery follows the annex. Whether xylazine is available on prescription, over the counter or on general sale is a question for the Latvian medicines and pharmacy regime, which this row did not audit. The State Agency of Medicines of Latvia is the body that answers it. Treat the supply route for xylazine as unread rather than as open.
Documentation: Carry xylazine as the Latvian medicines and pharmacy regime allows and do not read this row as a carriage permission, because a substance that is off the controlled list is not thereby free to cross a border. That is the carriage answer for xylazine and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for xylazine appears in what was read here. Provenance follows. Annex 2 to the law on the entry into force and application of the Criminal Law was searched in Latvian on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026, and no entry was located. The final page of Annex 2 was read, so the search reached the end of the instrument rather than stopping part way.

Latvia, Xylazine, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · searched in Annex 2 to the law on the entry into force and application of the Criminal Law and no entry for xylazine was located · Latvian search terms recorded: ksilazīns · xylazine · CAS 7361-61-7 · Annex 2 prints no small ceiling and no large floor for this row · this absence is stated as at the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Xylazine in Latvia, full detail →

Zolpidem

Legal status: Zolpidem is controlled in Latvia. The controlling instrument is Annex 2 to the law on the entry into force and application of the Criminal Law, and section 3(2) of the Circulation Law points to it expressly, which is why the former Cabinet Regulation No. 847 is not the current list. Annex 2 names zolpidem directly. The entry reads «zolpidēms», which is zolpidem. The entry sits at item 16(72) of Annex 2, in Schedule III, which covers dangerous psychotropic substances. Control extends to specified derivatives, isomers, structural analogues, active metabolites, salts, medicines, plant preparations and mixtures under Circulation Law sections 3(3)(5), 3(3)(6) and 3(4) read with Annex 2 paragraphs 2 and 3. This reading is stated as in force on 18 September 2026. Annex 2 identifies its current version as the 29 April 2021 text, as amended to 13 November 2025, with the cited 2025 change taking effect on 1 December 2025.
Consequences if caught: Capital exposure: none. Latvia has no death penalty and no life sentence for a drug offence, so neither is available for zolpidem. The ceiling is 15 years under subsection (3) of Criminal Law section 253 with a superscript one, which is reached by an organised group, a large amount, serious consequences, sale to a minor, or sale at specified public or educational venues. The scale runs from an administrative penalty to fifteen years. Circulation Law section 48(1) makes unauthorised acquisition or possession in a small amount, or unauthorised use, punishable by a warning or 10 to 56 fine units, and section 48(3) requires a written warning about criminal liability if it happens again within a year. Criminal Law section 253(1) covers handling without intent to sell at up to 3 years, and section 253(2) reaches 3 to 10 years for a group or a large amount. The sale provision, numbered 253 with a superscript one, covers sale-purpose conduct and sale at 2 to 8 years in its subsection (1), reaches 3 to 10 years in its subsection (2), and reaches 5 to 15 years in its subsection (3). Annex 2 prints the two cut-offs for this entry: the amount up to which a quantity is recognised as small is 0,6 g, and the amount from which a quantity is recognised as large is 10 g. The printed small ceiling and the printed large floor are not the same boundary. A quantity above the small ceiling but below the large floor is neither small nor large under those two columns, and falls into the ordinary band between them.
If prescribed / medical: There is a medical route for zolpidem and it runs inside the control regime rather than around it. Annex 2 places it in Schedule III, as a dangerous psychotropic substance, which is the schedule level that keeps a substance available for medical and scientific use under the Circulation Law licensing and prescribing rules. The prescribing and dispensing conditions themselves sit in the Latvian medicines and pharmacy regime, which this row did not audit, so treat the detail of the route as unread. The State Agency of Medicines of Latvia is the body that states it.
Documentation: Carry the prescription and the original dispensing packaging for zolpidem, and get the State Agency of Medicines of Latvia to confirm the position in writing before you travel rather than at the border. That is the carriage answer and it is short because no traveller permit scheme, declaration form or carriage allowance for zolpidem appears anywhere in what was read for this row, and an absence in what was read is not proof that no scheme exists. Provenance follows. The controlling text was read on likumi.lv, the official consolidated law portal of Latvia, on 18 September 2026: Annex 2 to the law on the entry into force and application of the Criminal Law, the Circulation Law, and the Criminal Law itself. The basis recorded for this row is a named entry. The instrument pages carry no separate reuse licence, so this row uses short attributed quotation and a link to the official text.

Latvia, Zolpidem, read from likumi.lv, the official consolidated law portal of the Republic of Latvia · read as in force on 18 September 2026 · located in Annex 2 to the law on the entry into force and application of the Criminal Law, at item 16(72), in Schedule III, which covers dangerous psychotropic substances · the entry itself is quoted in full in the legal status field and is not repeated here · the basis is a named entry · printed quantities: small up to 0,6 g, large from 10 g · Circulation Law section 3(2) points to Annex 2, and Criminal Law section 253 with its superscript one and superscript two variants supplies the penalties · Annex 2 is the 29 April 2021 text as amended to 13 November 2025 · likumi.lv · likumi.lv · likumi.lv · Updated September 20, 2026

Zolpidem in Latvia, full detail →

Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.

Before you travel

Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.

If you’re detained or arrested abroad

Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →

← All countries Drug index